These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 14588107)

  • 1. Carcinoembryonic antigen mRNA in blood: distinguishing follicular thyroid carcinoma from adenoma.
    Sato T; Nakano S; Yamashita J
    Thyroid; 2003 Sep; 13(9):891-2. PubMed ID: 14588107
    [No Abstract]   [Full Text] [Related]  

  • 2. Promising molecular techniques for discriminating among follicular thyroid neoplasms.
    Carroll NM; Carty SE
    Surg Oncol; 2006 Aug; 15(2):59-64. PubMed ID: 16949814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating tumor cells detected by reverse transcription-polymerase chain reaction for carcinoembryonic antigen mRNA: distinguishing follicular thyroid carcinoma from adenoma.
    Sato T; Harao M; Nakano S; Jotsuka T; Suda N; Yamashita J
    Surgery; 2005 May; 137(5):552-8. PubMed ID: 15855928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case with poorly differentiated follicular carcinoma of the thyroid produced and secreted CEA].
    Kobayashi K; Yokozawa T; Ito Y; Matsuzuka H; Kuma K; Miyauchi A; Kakudo K
    Nihon Geka Gakkai Zasshi; 2003 Jun; 104(6):488-90. PubMed ID: 12854498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomerase activity: a marker to distinguish follicular thyroid adenoma from carcinoma.
    Umbricht CB; Saji M; Westra WH; Udelsman R; Zeiger MA; Sukumar S
    Cancer Res; 1997 Jun; 57(11):2144-7. PubMed ID: 9187112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of blood and nucleic acid testing in diagnosis of thyroid carcinoma].
    Takano T
    Nihon Rinsho; 2007 Nov; 65(11):1991-5. PubMed ID: 18018560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The clinical usefulness of tumor markers in thyroid neoplastic pathology. Our experience].
    Gerardi G; De Angelis P
    Minerva Med; 1994 May; 85(5):237-40. PubMed ID: 8028752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of the thyroid peroxidase marker for distinguishing follicular thyroid carcinoma from follicular adenoma.
    Savin S; Cvejic D; Isic T; Paunovic I; Tatic S; Havelka M
    Exp Oncol; 2006 Mar; 28(1):70-4. PubMed ID: 16614712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follicular lesions of the thyroid.
    Mathur A; Olson MT; Zeiger MA
    Surg Clin North Am; 2014 Jun; 94(3):499-513. PubMed ID: 24857573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring serum thyroglobulin in patients with follicular thyroid nodule: its diagnostic implications.
    Okamoto T; Kanbe M; Iihara M; Yamazaki K; Okamoto J; Yamashita T; Ito Y; Kawakami M; Obara T
    Endocr J; 1997 Feb; 44(1):187-93. PubMed ID: 9152633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comment on: synchronous occurrence of anaplastic, follicular, and papillary carcinoma with follicular adenoma in thyroid gland.
    Wasim NA; Hati GC; Guha D; Bhattacharya S
    Indian J Pathol Microbiol; 2011; 54(2):434-5. PubMed ID: 21623130
    [No Abstract]   [Full Text] [Related]  

  • 12. Synchronous occurrence of anaplastic, follicular and papillary carcinomas with follicular adenoma in thyroid gland.
    Bhargav PR; Gayathri KB
    Indian J Pathol Microbiol; 2011; 54(2):414-5; author reply 415. PubMed ID: 21623114
    [No Abstract]   [Full Text] [Related]  

  • 13. Detection of recurrent thyroid cancer by sensitive nested reverse transcription-polymerase chain reaction of thyroglobulin and sodium/iodide symporter messenger ribonucleic acid transcripts in peripheral blood.
    Biscolla RP; Cerutti JM; Maciel RM
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3623-7. PubMed ID: 11061512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Approach to thyroid incidentaloma and follicular adenoma].
    Tajiri J
    Nihon Rinsho; 2007 Nov; 65(11):2099-105. PubMed ID: 18018577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The fifteen percent issue in molecular-based diagnosis of follicular thyroid carcinoma.
    Takano T
    Pathol Int; 2011 Mar; 61(3):165-6. PubMed ID: 21355960
    [No Abstract]   [Full Text] [Related]  

  • 16. Thyroid neoplasms of follicular cell derivation: a simplified approach.
    Asa SL; Mete O
    Semin Diagn Pathol; 2013 Aug; 30(3):178-85. PubMed ID: 24144287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of galectin-3 messenger ribonucleic Acid overexpression in papillary thyroid cancer by quantitative reverse transcription-polymerase chain reaction.
    Bernet VJ; Anderson J; Vaishnav Y; Solomon B; Adair CF; Saji M; Burman KD; Burch HB; Ringel MD
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4792-6. PubMed ID: 12364475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular and capsular pseudoinvasion in thyroid neoplasms.
    Chebib I; Opher E; Richardson ME
    Int J Surg Pathol; 2009 Dec; 17(6):449-51. PubMed ID: 19666948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncofoetal fibronectin--a tumour-specific marker in detecting minimal residual disease in differentiated thyroid carcinoma.
    Hesse E; Musholt PB; Potter E; Petrich T; Wehmeier M; von Wasielewski R; Lichtinghagen R; Musholt TJ
    Br J Cancer; 2005 Sep; 93(5):565-70. PubMed ID: 16091757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of p53 and soluble Fas ligand (sFasL) serum level concentration as indicators of apoptosis in serum of patients with benign and malignant primary follicular thyroid tumors].
    Kołomecki K; Maciaszczyk P; Stepień H; Cywiński J; Cielecka J; Stepień T; Kuzdak K
    Endokrynol Pol; 2006; 57(4):320-5. PubMed ID: 17006831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.